Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Pharyngeal cancer, Secondary cancers
Results
Phase 3
This trial compared nivolumab and ipilimumab with for head and neck cancer.
It was for people who:
had head and neck cancer
were having their first treatment for cancer that had come back or spread
People could join the trial between 2017 and 2018. The team published the final results in 2022.
Recruitment start: 9 March 2017
Recruitment end: 26 November 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kevin Harrington
Bristol-Myers Squibb
The trial team are hugely grateful to the patients and their families for agreeing to take part in this trial. By doing this, you’ve helped the research team learn more about cancer and how to treat it.
Last reviewed: 01 Jul 2026
CRUK internal database number: 14715
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
